E859-1802 Screening compound: N-(3-acetylphenyl)-1-{3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl}piperidine-3-carboxamide

E859-1802 Screening compound: N-(3-acetylphenyl)-1-{3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl}piperidine-3-carboxamide
E859-1802 Screening compound: N-(3-acetylphenyl)-1-{3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl}piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E859-1802
N-(3-acetylphenyl)-1-{3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl}piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E859-1802

Molecular Formula

C27H28N6O2 (C27 H28 N6 O2)

Compound Name

N-(3-acetylphenyl)-1-{3,4-dimethyl-2-phenyl-2H-pyrazolo[3,4-d]pyridazin-7-yl}piperidine-3-carboxamide

IUPAC name

N-(3-acetylphenyl)-1-{34-dimethyl-2-phenyl-2H-pyrazolo[34-d]pyridazin-7-yl}piperidine-3-carboxamide

SMILES

CC(c1cccc(NC(C(CCC2)CN2c2nnc(C)c3c(C)n(-c4ccccc4)nc23)=O)c1)=O

InChI

InChI=1S/C27H28N6O2/c1-17-24-18(2)33(23-12-5-4-6-13-23)31-25(24)26(30-29-17)32-14-8-10-21(16-32)27(35)28-22-11-7-9-20(15-22)19(3)34/h4-7,9,11-13,15,21H,8,10,14,16H2,1-3H3,(H,28,35)/t21-/m0/s1

InChI Key

ACVOPNBNPQPGQC-NRFANRHFSA-N

MDL Number (MFCD)

MFCD14924000

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.066

Distribution Coefficient, logD

3.046

Water Solubility, LogSw

-3.52

Polar Surface Area

77.122

Acid Dissociation Constant (pKa)

10.15

Base Dissociation Constant (pKb)

6.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.60

E859-1802 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with E859-1802 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E859-1802?
Check Price and Availability of E859-1802, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E859-1802 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E859-1802
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E859-1802
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E859-1802 available by request